Nivolumab,Relatlimab,Ipilimumab
BMS
[' ipi ', 'nivo']
today's results from #asco2023 : - better pfs with combining drugs ? no surprise ( - more tox with rela-nivo ? no surprise
- os not better ? yet ?
but be cautious : access to ipi post rela is ... substandard makes survival results less reliable
5/7 
Medicine, Oncology (sarcoma, H&N, CUP), Research = EBM, Epi, Policy #metaresearch @Hopitaux_unige (Geneva, CH), @vkprasadlab (UCSF). No COI. Views mine.